JPX · 4592.T
SanBio Company Limited
¥917-¥27 (-2.86%)
SanBio Company Limited’s quoted price sits in the lower half of its reported 52-week range, 68.74% below the high.
Loading market information…
JPX · 219A.T · JPY
Stock price, earnings
Quote as of Oct 30, 2026, 06:30 AM UTC. Cached market data; not a live quote.
One-year closing-price history · JPY. Historical prices are not a forecast.
Heartseed, Inc.’s quoted price sits in the upper half of its reported 52-week range, 6.07% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Heartseed, Inc.’s next earnings report is currently expected on Nov 13, 2026. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Heartseed, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Heartseed Inc. is a Japan-based company engaged in research and development of regenerative medicine products. The company has established cardiac regenerative medicine, a therapy in which microtissue derived from iPS cells is transplanted into the heart for patients with severe heart failure. Target diseases include dilated cardiomyopathy, old myocardial infarction, and dilated-phase hypertrophic cardiomyopathy.
Latest available per-share figures in JPY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 01:20 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
¥917-¥27 (-2.86%)
SanBio Company Limited’s quoted price sits in the lower half of its reported 52-week range, 68.74% below the high.
¥7,060-¥290 (-3.95%)
Cuorips Inc.’s quoted price sits in the lower half of its reported 52-week range, 43.06% below the high.
¥355-¥17 (-4.57%)
3-D Matrix, Ltd.’s quoted price sits in the lower half of its reported 52-week range, 55.23% below the high.
¥629-¥138 (-17.99%)
Japan Tissue Engineering Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 32.15% below the high.
¥498+¥2 (+0.4%)
Innovacell Inc.’s quoted price sits in the lower half of its reported 52-week range, 60.1% below the high.
¥139-¥7 (-4.79%)
StemRIM’s quoted price sits in the lower half of its reported 52-week range, 62.23% below the high.
¥188-¥7 (-3.59%)
CellSeed Inc.’s quoted price sits in the lower half of its reported 52-week range, 57.66% below the high.
¥559-¥5 (-0.89%)
Cyfuse Biomedical K.K.’s quoted price sits in the lower half of its reported 52-week range, 26.83% below the high.
